Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
OPERATING EXPENSES
Amortization	$ 57,344	$ 57,344	$ 172,032	$ 172,033
Research and development expenses	353,198	331,834	1,003,124	732,373
Selling, general and administrative expenses	288,711	459,111	940,762	936,180
TOTAL OPERATING EXPENSES	699,253	848,289	2,115,918	1,840,586
LOSS FROM OPERATIONS	(699,253)	(848,289)	(2,115,918)	(1,840,586)
OTHER EXPENSE (INCOME)
Change in fair value of derivative liabilities	(366,550)		(8,125,328)
Gain on settlement of debt				(51,400)
Interest Expense	33,699		3,532,234	272
Interest income		(248)	(233)	(1,036)
TOTAL OTHER EXPENSE (INCOME)	(332,851)	(248)	(4,593,327)	(52,164)
NET INCOME (LOSS)	(366,402)	(848,041)	2,477,409	(1,788,422)
Deemed dividend			17,099,058	48,659
NET LOSS ATTRIBUTABLE TO COMPANY STOCKHOLDERS	$ (366,402)	$ (848,041)	$ (14,621,649)	$ (1,837,081)
NET LOSS PER COMMON SHARE, BASIC	$ (0.07)	$ (0.34)	$ (3.02)	$ (0.73)
NET LOSS PER COMMON SHARE, DILUTED	$ (0.07)	$ (0.34)	$ (3.02)	$ (0.73)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC	5,183,724	2,520,429	4,661,183	2,497,457
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, DILUTED	5,183,724	2,520,429	4,661,183	2,497,457